Frascà G M, Balestra E, Fanciulli E, Freddi P, Mazzucchelli R, Montironi R, D'Arezzo M, Sagripanti S
Nefrologia, Ospedali Riuniti, Ancona, Italy.
G Ital Nefrol. 2008 Jan-Feb;25(1):49-56.
Thin glomerular basement membrane disease (TBMD) is a hereditary nephropathy characterized by thinning of the glomerular basement membrane evinced by electron microscopy and, clinically, by isolated hematuria without extrarenal manifestations. Familial aggregation is found in 50-60% of cases, with autosomal dominant transmission. TBMD is considered to belong to the type IV collagen spectrum of diseases, since heterozygous mutations of the COL4A3 or COL4A4 gene have been detected in more than 30% of patients. The disease is found in 1-2% of biopsies, but the prevalence in the general population may be higher. The differential diagnosis with Alport's syndrome may be difficult and requires accurate family investigations, immunohistochemical evaluation of type IV collagen alpha chains in renal tissue and, if appropriate, genetic studies. Progression towards chronic renal failure, although rare, has been reported in some patients, and may be related to the phenotypical variability of COL4A3/COL4A4 mutations, to a missed Alport syndrome, or to superimposed glomerular disease. Patients suffering from TBMD and affected relatives should be periodically examined for signs of disease progression and informed about the possibility of transmitting the autosomal recessive form of Alport's syndrome.
薄肾小球基底膜病(TBMD)是一种遗传性肾病,其特征在于电子显微镜显示肾小球基底膜变薄,临床上表现为孤立性血尿且无肾外表现。50%-60%的病例存在家族聚集性,呈常染色体显性遗传。由于超过30%的患者检测到COL4A3或COL4A4基因的杂合突变,TBMD被认为属于IV型胶原疾病谱。该病在1%-2%的活检病例中被发现,但在普通人群中的患病率可能更高。与Alport综合征的鉴别诊断可能困难,需要进行准确的家族调查、肾组织IV型胶原α链的免疫组化评估,以及在适当情况下进行基因研究。尽管罕见,但一些患者已报告有进展为慢性肾衰竭的情况,这可能与COL4A3/COL4A4突变的表型变异性、漏诊的Alport综合征或叠加的肾小球疾病有关。患有TBMD的患者及其受影响的亲属应定期检查疾病进展迹象,并告知他们可能会传递常染色体隐性形式的Alport综合征。